{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:47:15Z","timestamp":1793195235543,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"crossref","award":["2023D01C157"],"award-info":[{"award-number":["2023D01C157"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Xinjiang \u201cTianshan Talents\u201d Medical and Health High\u2011level Talent Program","award":["TSYC202301A073"],"award-info":[{"award-number":["TSYC202301A073"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01778-0","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:58:27Z","timestamp":1755154707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PEDF-Expressing mesenchymal stem cells restore ovarian function via Tim-3-Mediated immune modulation in primary ovarian failure"],"prefix":"10.1186","volume":"18","author":[{"given":"Seyida","family":"Yimamuyushan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikeremujiang","family":"Muheremu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"7","key":"1778_CR1","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/s41591-023-02405-5","volume":"29","author":"S Shekari","year":"2023","unstructured":"Shekari S, Stankovic S, Gardner EJ, et al. Penetrance of pathogenic genetic variants associated with premature ovarian insufficiency[J]. Nat Med. 2023;29(7):1692\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"1778_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13697137.2022.2153033","volume":"26","author":"M Li","year":"2023","unstructured":"Li M, Zhu Y, Wei J, et al. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis[J]. Climacteric. 2023;26(2):95\u2013102.","journal-title":"Climacteric"},{"key":"1778_CR3","doi-asserted-by":"publisher","first-page":"1113684","DOI":"10.3389\/fphys.2023.1113684","volume":"14","author":"T Zhang","year":"2023","unstructured":"Zhang T, He M, Zhang J, et al. Mechanisms of primordial follicle activation and new pregnancy opportunity for premature ovarian failure patients[J]. Front Physiol. 2023;14:1113684.","journal-title":"Front Physiol"},{"key":"1778_CR4","doi-asserted-by":"publisher","first-page":"998424","DOI":"10.3389\/fphys.2022.998424","volume":"13","author":"J Wang","year":"2023","unstructured":"Wang J, Sun X, Yang Z, et al. Epigenetic regulation in premature ovarian failure: A literature review[J]. Front Physiol. 2023;13:998424.","journal-title":"Front Physiol"},{"issue":"2","key":"1778_CR5","doi-asserted-by":"publisher","first-page":"100005","DOI":"10.1016\/j.labinv.2022.100005","volume":"103","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhuo A, Yang Y, et al. Regulatory T cells overexpressing peli1 show better efficacy in repairing ovarian endocrine function in autoimmune premature ovarian insufficiency[J]. Lab Invest. 2023;103(2):100005.","journal-title":"Lab Invest"},{"key":"1778_CR6","doi-asserted-by":"crossref","unstructured":"Nouri N, Aghebati-Maleki L, Soltani-Zangbar MS et al. Analysis of Th17 cell population and expression of MicroRNA and factors related to Th17 in patients with premature ovarian failure[J]. J Reprod Immunol, 2024: 104290.","DOI":"10.1016\/j.jri.2024.104290"},{"key":"1778_CR7","doi-asserted-by":"publisher","first-page":"103799","DOI":"10.1016\/j.jri.2023.103799","volume":"156","author":"Z Chen","year":"2023","unstructured":"Chen Z, Huang J, Kwak-Kim J, et al. Immune checkpoint inhibitors and reproductive failures[J]. J Reprod Immunol. 2023;156:103799.","journal-title":"J Reprod Immunol"},{"key":"1778_CR8","doi-asserted-by":"publisher","first-page":"106837","DOI":"10.1016\/j.imlet.2024.106837","volume":"266","author":"H Ahmadi","year":"2024","unstructured":"Ahmadi H, Soltani-Zangbar MS, Yousefi M, et al. The evaluation of PD-1 and Tim-3 expression besides their related MiRNAs in PBMCs of women with recurrent pregnancy loss[J]. Immunol Lett. 2024;266:106837.","journal-title":"Immunol Lett"},{"issue":"20","key":"1778_CR9","first-page":"10856","volume":"15","author":"M Marchante","year":"2023","unstructured":"Marchante M, Ramirez-Martin N, Buigues A, et al. Deciphering reproductive aging in women using a NOD\/SCID mouse model for distinct physiological ovarian phenotypes[J]. Aging. 2023;15(20):10856.","journal-title":"Aging"},{"key":"1778_CR10","doi-asserted-by":"publisher","first-page":"1165574","DOI":"10.3389\/fendo.2023.1165574","volume":"14","author":"C Guo","year":"2023","unstructured":"Guo C, Ma Y, Situ Y, et al. Mesenchymal stem cells therapy improves ovarian function in premature ovarian failure: a systematic review and meta-analysis based on preclinical studies[J]. Front Endocrinol. 2023;14:1165574.","journal-title":"Front Endocrinol"},{"issue":"3","key":"1778_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12015-022-10493-y","volume":"19","author":"A Umer","year":"2023","unstructured":"Umer A, Khan N, Greene DL, et al. The therapeutic potential of human umbilical cord derived mesenchymal stem cells for the treatment of premature ovarian failure[J]. Stem Cell Reviews Rep. 2023;19(3):651\u201366.","journal-title":"Stem Cell Reviews Rep"},{"issue":"1","key":"1778_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13287-023-03297-5","volume":"14","author":"G Ai","year":"2023","unstructured":"Ai G, Meng M, Guo J, et al. Adipose-derived stem cells promote the repair of chemotherapy-induced premature ovarian failure by inhibiting granulosa cells apoptosis and senescence[J]. Stem Cell Res Ther. 2023;14(1):75.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"1778_CR13","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1177\/0271678X20943823","volume":"40","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research[J]. J Cereb Blood Flow Metabolism. 2020;40(9):1769\u201377.","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"1778_CR14","unstructured":"Institute of Laboratory Animal Resources (US). Committee on care, use of laboratory animals. Guide for the care and use of laboratory animals[M]. US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1986."},{"issue":"1","key":"1778_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11817\/j.issn.1672-7347.2018.01.002","volume":"43","author":"J Peng","year":"2018","unstructured":"Peng J, Xiao N, Cheng L. Therapeutic potential of BMSCs for premature ovarian failure in mice. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(1):7\u201313. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2018.01.002. Chinese. PMID: 30154285.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"5","key":"1778_CR16","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.15419\/bmrat.v11i5.891","volume":"11","author":"ED Manshadi","year":"2024","unstructured":"Manshadi ED, Rezvani ME, Hassanpour A, et al. Reduction of apoptotic gene expression by Platelet-rich plasma in a mouse model of premature ovarian Failure[J]. Biomedical Res Therapy. 2024;11(5):6447\u201356.","journal-title":"Biomedical Res Therapy"},{"issue":"2","key":"1778_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMcp2116488","volume":"388","author":"CA Stuenkel","year":"2023","unstructured":"Stuenkel CA, Gompel A. Primary ovarian insufficiency[J]. N Engl J Med. 2023;388(2):154\u201363.","journal-title":"N Engl J Med"},{"key":"1778_CR18","doi-asserted-by":"publisher","first-page":"1361573","DOI":"10.3389\/fendo.2024.1361573","volume":"15","author":"H Cao","year":"2024","unstructured":"Cao H, Li H, Lin G, et al. The clinical value of acupuncture for women with premature ovarian insufficiency: a systematic review and meta-analysis of randomized controlled trials[J]. Front Endocrinol. 2024;15:1361573.","journal-title":"Front Endocrinol"},{"key":"1778_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.reth.2023.11.007","volume":"25","author":"F Kuchakzadeh","year":"2024","unstructured":"Kuchakzadeh F, Ai J, Ebrahimi-Barough S. Tissue engineering and stem cell-based therapeutic strategies for premature ovarian insufficiency[J]. Regenerative Therapy. 2024;25:10\u201323.","journal-title":"Regenerative Therapy"},{"key":"1778_CR20","first-page":"312","volume":"79","author":"MB Valloton","year":"1966","unstructured":"Valloton MB, Forbes AP. Antibodies to human kidney and thyroid in systemic lupus erythematosus. Trans Assoc Am Physicians. 1966;79:312\u201321.","journal-title":"Trans Assoc Am Physicians"},{"key":"1778_CR21","doi-asserted-by":"crossref","unstructured":"Lang T, Hua S, Du J et al. Investigation of the causal relationship between autoimmune diseases and premature ovarian Insufficiency[J]. Reproductive Sci, 2024: 1\u201311.","DOI":"10.1007\/s43032-024-01603-x"},{"key":"1778_CR22","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s10815-019-01572-0","volume":"36","author":"M Kirshenbaum","year":"2019","unstructured":"Kirshenbaum M, Orvieto R. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal[J]. J Assist Reprod Genet. 2019;36:2207\u201315.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"1778_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4252\/wjsc.v16.i1.1","volume":"16","author":"H Hu","year":"2024","unstructured":"Hu H, Xin X, Zhu Y, et al. Application of mesenchymal stem cell therapy for premature ovarian insufficiency: recent advances from mechanisms to therapeutics[J]. World J Stem Cells. 2024;16(1):1.","journal-title":"World J Stem Cells"},{"key":"1778_CR24","doi-asserted-by":"crossref","unstructured":"Sadeghi S, Mosaffa N, Huang B et al. Protective role of stem cells in POI: current status and mechanism of action, a review article[J]. Heliyon, 2024.","DOI":"10.1016\/j.heliyon.2023.e23271"},{"issue":"2","key":"1778_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00404-023-07062-0","volume":"309","author":"L Hu","year":"2024","unstructured":"Hu L, Tan R, He Y, et al. Stem cell therapy for premature ovarian insufficiency: a systematic review and meta-analysis of animal and clinical studies[J]. Arch Gynecol Obstet. 2024;309(2):457\u201367.","journal-title":"Arch Gynecol Obstet"},{"key":"1778_CR26","doi-asserted-by":"crossref","unstructured":"Devi SSK, Singh S, Joga R et al. Enhancing cancer immunotherapy: exploring strategies to target the PD-1\/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape[J]. Eur J Pharm Biopharm, 2024: 114323.","DOI":"10.1016\/j.ejpb.2024.114323"},{"key":"1778_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06492.x","volume":"1253","author":"GA Rabinovich","year":"2012","unstructured":"Rabinovich GA, van Kooyk Y, Cobb BA. Glycobiology of immune responses. Ann N Y Acad Sci. 2012;1253:1\u201315.","journal-title":"Ann N Y Acad Sci"},{"key":"1778_CR28","doi-asserted-by":"publisher","first-page":"109645","DOI":"10.1016\/j.intimp.2022.109645","volume":"115","author":"H Hong","year":"2023","unstructured":"Hong H, Xue G, Zhang Y, et al. Effect of exogenous galectin-9, a natural TIM-3 ligand, on the severity of TNBS-and DSS-induced colitis in mice[J]. Int Immunopharmacol. 2023;115:109645.","journal-title":"Int Immunopharmacol"},{"key":"1778_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2021.08.063","volume":"577","author":"K Bahrehbar","year":"2021","unstructured":"Bahrehbar K, Malakhond MK, Gholami S. Tracking of human embryonic stem cell-derived mesenchymal stem cells in premature ovarian failure model mice[J]. Biochem Biophys Res Commun. 2021;577:6\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"1778_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13287-024-03698-0","volume":"15","author":"W Pei","year":"2024","unstructured":"Pei W, Fu L, Guo W, et al. Efficacy and safety of mesenchymal stem cell therapy for ovarian ageing in a mouse model. Stem Cell Res Ther. 2024;15:96. https:\/\/doi.org\/10.1186\/s13287-024-03698-0.","journal-title":"Stem Cell Res Ther"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01778-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01778-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01778-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:19:40Z","timestamp":1757456380000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01778-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1778"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01778-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved by the ethics committee of the Fifth Affiliated Hospital of Xinjiang Medical University (ethics approval number: SKL-HIDCA2024-GX4). All the procedures followed the guidelines of Helsinki. All animal experiments complied with the ARRIVE guidelines and were carried out in accordance with the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}